BRCA1 and BRCA2 Large Genomic Rearrangements Screening in Thai Familial Breast Cancer Patients by Multiplex Ligation-dependent  Probe Amplification (MLPA)

Sunichya Jadsri; Takol Chareonsirisuthigul; Budsaba Rerkamnuaychoke; Donniphat Dejsuphong; Atchara Tunteeratum; Surakameth Mahasirimongkol

Authors

Sunichya Jadsri Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand 10400
Takol Chareonsirisuthigul Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand 10400
Budsaba Rerkamnuaychoke Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand 10400
Donniphat Dejsuphong Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand 10400
Atchara Tunteeratum Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand 10400
Surakameth Mahasirimongkol Medical Genetics Section, National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand 11000

Keywords:

Breast Cancer, BRCA1/2 Mutation, Multiplex Ligation-dependent Probe Amplification (MLPA)

Abstract

Breast Cancer has now become the most frequently diagnosed cancer and the leading cause of cancer death in females. BRCA1 and BRCA2 inherited mutations account for 5%-10% of all female breast cancers. However, prevalence of BRCA genes mutation is vary in between difference populations. In Thailand, there are no previous studies of BRCA1 and BRCA2 large genomics rearrangement (LGRs) have been reported. In this study, we screened the ‘‘high-risk’’ group consisted of 100 individuals who met clinical criteria for genetic examination of BRCA1/2 using Multiplex Ligation-dependent Probe Amplification (MLPA). Among a total of 100 selected cases, one duplication of BRCA1 exon 15 was determined but none of any LGRs were found in BRCA2. Similar to the other studies in Asian population, the prevalence of LGRs in Thailand likely to be low. The information of BRCA1 and BRCA2 LGRs from this study can be used as a nationwide of Thai database which will be useful for further study of the familial breast cancer.

References

De Silva, S., Tennekoon, K. H., Karunanayake, E. H., Amarasinghe, I., & Angunawela, P. (2014). Analysis of BRCA1and BRCA2 large genomic rearrangements in Sri Lankan familial breast cancer patients and at risk individuals. BMC Research Notes, 7, 344. doi: 10.1186/1756-0500-7-344.

Ewald, I. P., Ribeiro, P. L., Palmero, E. I., Cossio, S. L., Giugliani, R., & Ashton-Prolla, P. (2009). Genomic rearrangements in BRCA1 and BRCA2: a literature review. Genet Mol Biol., 32, 437–446.

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo,M., … Bray, F. (2015). Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. Int J Cancer, 136, E359–E386. doi: 10. 1002/ijc.29210.Epub2014Oct 9.

International Agency for Research on Cancer. Latest world cancer statistics Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed. Retrieved from https://www.iarc.fr/en/media-centre/pr/2013/pdfs /pr223_E.pdf

International Agency for Research on Cancer GLOBOCAN. (2012). Estimated cancer incidence, mortality and prevalence worldwide in 2012. Retrieved from http://globocan.iarc.fr/Pages/fact _sheets_cancer.aspx?cancer=all

Kang, P., Mariapun, S., Phuah, S. Y., Lim, L. S., Liu, J. , Yoon, S. Y., … Teo, S. H. (2010). Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families. Breast Cancer Res Treat, 124, 579–584. doi: 10.1007/s10549-010-1018-5. Epub 2010 Jul 9.

Kwong, A., Ng, E. K., Law, F. B., Wong, H. N., Wa, A., Wong, C.L., … Ma, E. S. K. (2012). Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients. Breast Cancer Res Treat, 136, 931–933. doi: 10.1007/s10549-012-2292-1. Epub 2012 Oct 26

Lim, Y. K., Iau, P. T. C., Ali, A. B., Lee, S. C., Wong, J. E-L., Putti, T. C., Sng, J-H. (2007). Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet, 71, 331–342. doi: 10.1111/j.1399-0004.2007. 00773.x

Mazoyer, S. (2005). Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat, 25(5), 415-22.

National Center Institute Department of Medical Services Ministry of Public Health (2014). Hospital based cancer registry annual report 2012. Bangkok, Thailand: Eastern Printing Public.

Petrucelli, N., Daly, M. B., & Feldman, G. L. (2013). BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer. GeneReviews® Retrieved from http://www.ncbi.nlm. nih.gov/books/NBK1247/

Seong, M. W., Cho, S. I., Kim, K. H., Chung, I. Y., Kang, E., Lee, J. W, … Kim, S. W. (2014). A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients. BMC Cancer, 14, 645. doi: 10.1186/1471-2407-14-645.

Stuppia, L., Antonucci, I., Palka, G., & Gatta, V. (2012). Use of the MLPA Assay in the Molecular Diagnosis of Gene Copy Number Alterations in Human Genetic Diseases. Int J Mol Sci, 13(3), 3245–3276. doi: 10.3390/ijms13033245

Youlden, D. R., Cramb, S. M., Yip, C. H., & Baade, P. D. (2014). Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med, 11, 101-115. doi: 10.7497/j. issn.2095-3941.2014.02.005